1. Home
  2. VVOS vs BGLC Comparison

VVOS vs BGLC Comparison

Compare VVOS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.50

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.61

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
BGLC
Founded
2016
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
4.9M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
VVOS
BGLC
Price
$0.50
$2.61
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
3.6M
59.6K
Earning Date
04-15-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
45.78
EPS
N/A
N/A
Revenue
$17,443,000.00
$7,424,911.00
Revenue This Year
$69.66
N/A
Revenue Next Year
$48.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.45
$1.07
52 Week High
$7.40
$15.19

Technical Indicators

Market Signals
Indicator
VVOS
BGLC
Relative Strength Index (RSI) 33.38 67.94
Support Level N/A $2.06
Resistance Level $0.76 $2.73
Average True Range (ATR) 0.14 0.31
MACD -0.01 0.05
Stochastic Oscillator 5.49 94.48

Price Performance

Historical Comparison
VVOS
BGLC

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: